Kunal Kishore Dhawan (Navia Life Care)

Overview

Kunal Kishore Dhawan is a prominent entrepreneur and investor in the Indian healthcare technology sector. He is well-known as the co-founder and CEO of Navia Life Care, a digital health startup that focuses on patient engagement and clinical outcomes through technology solutions. With a background in biotechnology and management from Carnegie Mellon University, Dhawan has leveraged his experience in the healthcare industry to foster innovation in healthtech. He has worked with notable organizations such as Fresenius Kabi, PwC, and Abbott before venturing into entrepreneurship.

Recent Developments

In recent years, Kunal Kishore Dhawan has continued to make significant strides in the Indian healthtech space:

2025: Kunal Kishore Dhawan is recognized as part of the ET 40 under 40 class, acknowledging his influence and contributions to the healthtech industry.
2023: Navia Life Care, under his leadership, plans to expand its reach, aiming to serve over 200,000 doctors and 200 million patients in more than 10 countries by 2025. This is part of a broader vision to bridge healthcare gaps.
2021-2022: The company secured $1 million in funding to enhance its digital health solutions, focusing on technology and product innovation.
2020 onwards: Dhawan has been expanding his portfolio by investing in and supporting other healthtech ventures as an angel investor, capitalizing on his sector expertise.

Personal Information

Attribute	Information
Full Name	Kunal Kishore Dhawan
Born	1985, Haryana, India
Nationality	Indian
Occupation	Entrepreneur, Investor
Known For	Co-founder and CEO of Navia Life Care
Education	Carnegie Mellon University (Masters in Biotechnology and Management)

Early Life and Education

Kunal Kishore Dhawan was born and raised in Haryana, India. His academic journey laid a strong foundation for his future endeavors in the healthtech sector. He pursued his higher education in biotechnology and management at Carnegie Mellon University, which equipped him with the technical and business acumen necessary for the healthcare industry. His educational background, coupled with internships and work experiences at major global companies, cultivated a deep understanding of the healthcare market.

Career and Notable Achievements

Dhawan's professional career spans various roles within the healthcare and life sciences industries before founding Navia Life Care in 2015.

2006-2015: Worked at significant entities like Fresenius Kabi, GSK, Abbott Vascular, and PwC, handling roles in strategy, business development, and market analysis.
2015: Co-founded Navia Life Care along with Gaurav Gupta and Shourjo Banerjee, establishing a startup focused on digital health solutions.
2017: Navia Life Care raised seed funding to further develop its platform, focusing on electronic medical records and patient engagement.
Achievements: Recognized in several startup contests and accolades, including YourStory's list of digital health startups to watch and the ET Catapooolt Changemakers campaign.

Current Work and Impact

As of 2025, Kunal Kishore Dhawan continues to be an influential figure in the healthtech space, primarily through his leadership at Navia Life Care and other entrepreneurial ventures like OSSO. His work focuses on leveraging technology to solve healthcare challenges, demonstrating a significant impact in improving patient engagement and healthcare delivery. His vision for Navia Life Care extends to global markets, aiming to tackle universal healthcare issues through innovative solutions.

Conclusion

Kunal Kishore Dhawan's contributions to the healthtech industry highlight the convergence of technology and healthcare in addressing modern-day challenges. His role in pioneering digital health solutions through Navia Life Care and his broader impact as an investor underscores his commitment to advancing healthcare accessibility and efficiency. As healthtech continues to evolve, Dhawan's efforts in fostering innovation and expanding digital health capabilities promise to leave a lasting legacy in the global healthcare ecosystem.